ArticleBMC pregnancy and childbirth2025
Effect of hCG day's estradiol levels on pregnancy outcomes following GnRH antagonist protocol: a retrospective study of 3192 fresh embryo transfer cycles.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundTo evaluate the impact of estradiol levels of hCG day (E2-hCG) on pregnancy outcomes in fresh embryo transfer (ET) cycles following antagonist protocol.
methodsThe retrospective study includes 3192 fresh ET cycles under antagonist protocol at Xiangya Hospital from October 2020 to July 2024. We evaluated the association of E2-hCG and pregnancy outcomes by generalized additive models adjusted for confounders. The turning point of E2-hCG is detected by segmentation regression. Pregnancy outcomes were compared across different E2-hCG ranges.
resultsWe detect a curved inverted U-shaped relationship between E2-hCG level and pregnancy outcomes. The pregnancy rates increased with the increase of E2-hCG levels, reaching the highest pregnancy rate at about 2400 pg/ml (turning point), and then the pregnancy rate decreased with the increase of E2-hCG levels. Based on the smooth curves, we divided the E2-hCG levels into three groups include E2-hCG < 1500 pg/ml, 1500 ≤ E2-hCG ≤ 4000 pg/mL, and E2-hCG > 4000 pg/ml. 1500 ≤ E2-hCG ≤ 4000 pg/mL increased 30% BPR (OR 1.30, 95%CI 1.07 ~ 1.56, p-value = 0.007) and 28% CPR (OR 1.28, 95%CI 1.07 ~ 1.54, p-value = 0.008) compared to E2-hCG < 1500 pg/mL. However, E2-hCG > 4000 pg/mL did not significantly increase BPR (OR 1.13, 95%CI 0.80 ~ 1.60, p-value = 0.50) and CPR (OR 1.07, 95%CI 0.76 ~ 1.50, p-value = 0.71) compared to E2-hCG < 1500 pg/mL.
conclusionsFor fresh ET under antagonist protocol, hCG day’s estradiol levels have an inverted U-shaped effect on pregnancy outcomes, with the highest pregnancy rate at a level of about 2400 pg/ml. We can get an ideal pregnancy rate when E2-hCG ranges from 1500 to 4000 pg/ml compared to E2-hCG < 1500 pg/ml or E2-hCG > 4000 pg/ml. Pregnancy outcomes are not significantly different between E2-hCG < 1500 pg/ml and E2-hCG > 4000 pg/ml groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.